Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mNEXSPIKE
Pharma
Sanofi's new COVID shot tops Moderna's mNexspike in safety trial
Sanofi’s Nuvaxovid has topped Moderna’s messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines.
Kevin Dunleavy
Apr 20, 2026 10:52am
Moderna outlines 3-year business strategy in bid to break even
Nov 20, 2025 2:54pm
Moderna says updated mNEXSPIKE induces strong immune response
Sep 23, 2025 10:15am
GSK adds Moderna's next-gen COVID shot to mRNA patent lawsuit
Sep 5, 2025 10:06am
Moderna's next-gen COVID shot gets FDA backing
Jun 2, 2025 9:01am
